EcoDrugPlus

Ensembl ID : ENSSVLG00005016411
Gene Symbol: -
Cross references: -
111 Possible Orthologues:

Ensembl ID : ENSSVLG00005016582
Gene Symbol: -
Cross references: -
164 Possible Orthologues:

Ensembl ID : ENSSVLG00005016814
Gene Symbol: -
Cross references: -
219 Possible Orthologues:

Ensembl ID : ENSSVLG00005017056
Gene Symbol: -
Cross references: -
221 Possible Orthologues:

Ensembl ID : ENSSVLG00005017435
Gene Symbol: -
Cross references: -
157 Possible Orthologues:

Ensembl ID : ENSSVLG00005017498
Gene Symbol: -
Cross references: -
283 Possible Orthologues:

Ensembl ID : ENSSVLG00005017607
Gene Symbol: -
Cross references: -
232 Possible Orthologues:

Ensembl ID : ENSSVLG00005017761
Gene Symbol: -
Cross references: -
200 Possible Orthologues:

Ensembl ID : ENSSVLG00005019294
Gene Symbol: -
Cross references: -
243 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).